Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Cardiovascular Diseases 3Breast Neoplasms 2Stomach Neoplasms 1Sarcoidosis 1Rectal Neoplasms 1Metabolic Syndrome 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Lung Diseases, Interstitial 1Hodgkin Disease 1Fatigue 1Cardiotoxicity 1

Interventions

Cyclophosphamide 193fludarabine phosphate 121Peripheral Blood Stem Cell Transplantation 106Etoposide 106Mycophenolic Acid 94Filgrastim 91Doxorubicin 85Whole-Body Irradiation 83Tacrolimus 80Melphalan 78Brentuximab Vedotin 77Busulfan 74Radiotherapy 73fludarabine 67Cyclosporine 67Vinblastine 65Rituximab 60Dacarbazine 56Granulocyte Colony-Stimulating Factor 53Gemcitabine 52Antilymphocyte Serum 51Bleomycin 50Nivolumab 47Methotrexate 47Vincristine 46Prednisone 45Cytarabine 43pembrolizumab 36Carmustine 36Bendamustine Hydrochloride 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hodgkin Disease × Blood Pressure × Clear all
NCT04636255 2026-05-04

Physical Capacity in Hodgkin Lymphoma Survivors

University of Sao Paulo General Hospital

Phase NA Completed
40 enrolled
Lymphoid

Cardiovascular Diseases, Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡